HEADER TRANSCRIPTION 11-APR-07 2PHE TITLE MODEL FOR VP16 BINDING TO PC4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSCRIPTIONAL COACTIVATOR PC4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: C-TERMINAL CORE DOMAIN; COMPND 5 SYNONYM: SUB1 HOMOLOG, POSITIVE COFACTOR 4, P15, P14; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ALPHA TRANS-INDUCING PROTEIN; COMPND 10 CHAIN: C; COMPND 11 FRAGMENT: PART OF ACTIVATION DOMAIN; COMPND 12 SYNONYM: VMW65, ICP25, VP16 PROTEIN, ALPHA- TIF; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SUB1, PC4, RPO2TC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11A; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HERPES SIMPLEX VIRUS (TYPE 1 / STRAIN 17); SOURCE 13 ORGANISM_TAXID: 10299; SOURCE 14 STRAIN: 17; SOURCE 15 GENE: UL48; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS PC4, VP16, TRANSCRIPTION, COFACTOR, ACTIVATOR EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR H.R.A.JONKER,R.W.WECHSELBERGER,R.BOELENS,G.E.FOLKERS,R.KAPTEIN REVDAT 4 22-MAY-24 2PHE 1 REMARK REVDAT 3 16-MAR-22 2PHE 1 REMARK SEQADV REVDAT 2 24-FEB-09 2PHE 1 VERSN REVDAT 1 24-APR-07 2PHE 0 JRNL AUTH H.R.A.JONKER,R.W.WECHSELBERGER,R.BOELENS,G.E.FOLKERS, JRNL AUTH 2 R.KAPTEIN JRNL TITL STRUCTURAL PROPERTIES OF THE PROMISCUOUS VP16 ACTIVATION JRNL TITL 2 DOMAIN JRNL REF BIOCHEMISTRY V. 44 827 2005 JRNL REFN ISSN 0006-2960 JRNL PMID 15654739 JRNL DOI 10.1021/BI0482912 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.X, HADDOCK 1.2 REMARK 3 AUTHORS : BRUKER BIOSPIN (XWINNMR), DOMINGUEZ ET AL. REMARK 3 (HADDOCK) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE REPRESENTS A DOCKING REMARK 3 MODEL. THE STARTING STRUCTURE FOR PC4 WAS TAKEN FROM THE PDB REMARK 3 ENTRY 1PCF. REMARK 4 REMARK 4 2PHE COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-APR-07. REMARK 100 THE DEPOSITION ID IS D_1000042380. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 305 REMARK 210 PH : 5.6; 5.6 REMARK 210 IONIC STRENGTH : 100-450 MM; 100-450 MM REMARK 210 PRESSURE : 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 0.2 MM VP16AD U-15N OR U15N,13C, REMARK 210 0-0.5 MM PC4 OR PC4CTD, 50 OR REMARK 210 400 MM KCL, 50 MM PHOSPHATE REMARK 210 BUFFER PH 5.6, 2 M D6-GLYCINE, REMARK 210 H2O; 0.2 MM PC4 OR PC4CTD U-15N, REMARK 210 0-0.5 MM VP16AD, 50 OR 400 MM REMARK 210 KCL, 50 MM PHOSPHATE BUFFER PH REMARK 210 5.6, 2 M D6-GLYCINE, H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 15N-HSQCS; 13C-HNCACB; 13C-HNCO; REMARK 210 15N-NOESY-HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; INOVA REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMR 1, NMRPIPE 2.4, SPARKY REMARK 210 3.110, CNS 1.1 REMARK 210 METHOD USED : THE MODEL WAS CALCULATED USING REMARK 210 HADDOCK REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : TOP-RANKED ENSEMBLE, ACCORDING REMARK 210 TO THE AVERAGE INTERACTION REMARK 210 ENERGY AND BURIED SURFACE AREA REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 77 -86.75 61.80 REMARK 500 1 ALA C 471 40.50 -85.38 REMARK 500 1 ASP C 472 -41.72 -133.28 REMARK 500 1 ASP C 481 -58.11 -129.64 REMARK 500 1 ILE C 485 -26.86 -174.90 REMARK 500 2 ASP C 469 -55.94 -147.21 REMARK 500 2 PHE C 479 -98.82 -91.76 REMARK 500 3 LYS A 79 -167.36 -100.83 REMARK 500 3 LEU A 81 78.94 -118.53 REMARK 500 3 MET C 478 -44.86 -176.80 REMARK 500 3 ALA C 482 28.72 -79.55 REMARK 500 3 LEU C 483 -50.83 -171.76 REMARK 500 4 LYS B 100 -146.22 -100.40 REMARK 500 5 MET B 68 -0.59 78.08 REMARK 500 5 LEU C 483 -78.08 -81.38 REMARK 500 6 TRP A 88 -157.39 -99.19 REMARK 500 6 LYS B 100 -160.35 -117.79 REMARK 500 6 ASP C 469 -114.97 -139.59 REMARK 500 7 PHE B 76 78.00 -108.80 REMARK 500 7 LYS B 125 78.09 -107.79 REMARK 500 7 GLU C 476 49.86 -81.62 REMARK 500 7 GLN C 477 -46.78 -165.05 REMARK 500 8 PHE A 76 119.34 -161.16 REMARK 500 8 PRO A 91 32.00 -78.39 REMARK 500 8 LYS A 100 108.38 -167.29 REMARK 500 8 MET B 68 -50.76 74.93 REMARK 500 9 MET B 68 -12.80 76.01 REMARK 500 9 ARG B 99 47.97 -82.26 REMARK 500 9 LYS B 100 104.87 -161.78 REMARK 500 9 ILE C 485 -16.05 -151.13 REMARK 500 10 ALA C 467 23.84 -77.25 REMARK 500 10 LEU C 468 -53.91 -141.39 REMARK 500 10 MET C 478 -4.12 -145.01 REMARK 500 10 PHE C 479 -83.27 -71.48 REMARK 500 10 ILE C 485 -31.82 -168.47 REMARK 500 10 TYR C 488 -52.73 -161.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6099 RELATED DB: BMRB REMARK 900 BACKBONE CHEMICAL SHIFT ASSIGNMENTS FOR THE ACTIVATION DOMAIN OF REMARK 900 THE TRANSCRIPTIONAL ACTIVATOR VP16 REMARK 900 RELATED ID: 1PCF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN TRANSCRIPTIONAL COACTIVATOR PC4 C- REMARK 900 TERMINAL CORE DOMAIN REMARK 900 RELATED ID: 2PHG RELATED DB: PDB DBREF 2PHE A 62 126 UNP P53999 TCP4_HUMAN 63 127 DBREF 2PHE B 62 126 UNP P53999 TCP4_HUMAN 63 127 DBREF 2PHE C 465 490 UNP P06492 ATIN_HHV11 465 490 SEQADV 2PHE ALA A 61 UNP P53999 CLONING ARTIFACT SEQADV 2PHE ALA B 61 UNP P53999 CLONING ARTIFACT SEQRES 1 A 66 ALA MET PHE GLN ILE GLY LYS MET ARG TYR VAL SER VAL SEQRES 2 A 66 ARG ASP PHE LYS GLY LYS VAL LEU ILE ASP ILE ARG GLU SEQRES 3 A 66 TYR TRP MET ASP PRO GLU GLY GLU MET LYS PRO GLY ARG SEQRES 4 A 66 LYS GLY ILE SER LEU ASN PRO GLU GLN TRP SER GLN LEU SEQRES 5 A 66 LYS GLU GLN ILE SER ASP ILE ASP ASP ALA VAL ARG LYS SEQRES 6 A 66 LEU SEQRES 1 B 66 ALA MET PHE GLN ILE GLY LYS MET ARG TYR VAL SER VAL SEQRES 2 B 66 ARG ASP PHE LYS GLY LYS VAL LEU ILE ASP ILE ARG GLU SEQRES 3 B 66 TYR TRP MET ASP PRO GLU GLY GLU MET LYS PRO GLY ARG SEQRES 4 B 66 LYS GLY ILE SER LEU ASN PRO GLU GLN TRP SER GLN LEU SEQRES 5 B 66 LYS GLU GLN ILE SER ASP ILE ASP ASP ALA VAL ARG LYS SEQRES 6 B 66 LEU SEQRES 1 C 26 TYR GLY ALA LEU ASP MET ALA ASP PHE GLU PHE GLU GLN SEQRES 2 C 26 MET PHE THR ASP ALA LEU GLY ILE ASP GLU TYR GLY GLY HELIX 1 1 ASN A 105 ARG A 124 1 20 HELIX 2 2 ASN B 105 ARG B 124 1 20 HELIX 3 3 ASP C 469 GLU C 474 1 6 HELIX 4 4 GLU C 474 THR C 480 1 7 HELIX 5 5 ILE C 485 GLY C 489 5 5 SHEET 1 A 4 MET A 62 GLY A 66 0 SHEET 2 A 4 ARG A 69 PHE A 76 -1 O VAL A 71 N PHE A 63 SHEET 3 A 4 LYS A 79 MET A 89 -1 O LEU A 81 N ARG A 74 SHEET 4 A 4 MET A 95 SER A 103 -1 O LYS A 96 N TRP A 88 SHEET 1 B 4 MET B 62 GLN B 64 0 SHEET 2 B 4 ARG B 69 ASP B 75 -1 O VAL B 71 N PHE B 63 SHEET 3 B 4 VAL B 80 MET B 89 -1 O LEU B 81 N ARG B 74 SHEET 4 B 4 MET B 95 LEU B 104 -1 O LYS B 96 N TRP B 88 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1